Floatz logo

(+)-VINCRISTINE

Desmoid

Parabilis Medicines, Inc.Small moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Desmoid cohort.

Asset / SponsorPhaseRating
Nivolumab
Parabilis Medicines, Inc.
Phase 2B
Irinotecan
Parabilis Medicines, Inc.
Phase 1/2CCC
TIPIRACIL
Parabilis Medicines, Inc.
Phase 1/2CCC
Fog-001
Parabilis Medicines, Inc.
Phase 1/2CCC
Eloxatin
Parabilis Medicines, Inc.
Phase 1/2CCC

View all 10 →

Same molecule, other indications

(+)-VINCRISTINE is also rated in:

anaplastic large cell lymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →